Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Natco Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524816 P/E (TTM) :10.36
ISIN Demat:INE987B01026 Div & Yield %:0.68 EPS (TTM) :84.75
Book Value (RS) :461.79599 Market Cap (Rs Cr.):15731.22 Face Value (RS) :2
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.050.050.060.080.07
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio3.703.212.973.053.38
Fixed Assets1.151.100.770.630.69
Inventory6.615.883.582.412.56
Debtors3.633.823.443.623.53
Interest Cover Ratio114.57108.2690.629.5135.71
PBIDTM (%)60.2248.8039.5714.9831.37
PBITM (%)54.8443.9933.157.1624.40
PBDTM (%)59.7448.4039.2014.2330.69
CPM (%)50.5741.4333.5213.7925.68
APATM (%)45.1936.6127.105.9618.72
ROCE (%)32.7528.5816.172.779.25
RONW (%)28.6325.3814.332.547.78

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)